| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 22, 2008
From the Medical University of South Carolina and RHJ Department of Veterans Affairs Medical Center, Charleston (M.R.Z.); Medtronic, Inc, Minneapolis, Minn (T.D.B., Y.K.C., F.J.K.); University of Pennsylvania, Philadelphia (M.S.J.S.); University of Oklahoma Health Sciences Center, Oklahoma City (P.B.A.); St Thomas Hospital, Nashville, Tenn (M.F.A.); University of Florida, Gainesville (J.M.A.); Ohio State University, Columbus (W.T.A.); Texas Heart Institute, Houston (F.W.S.); Brigham and Woman's Hospital, Harvard University, Boston, Mass (L.W.-S.); and University of Alabama at Birmingham (R.C.B.). * To whom correspondence should be addressed. E-mail: zilem{at}musc.edu.
Background—Approximately half of all patients with chronic heart failure (HF) have a decreased ejection fraction (EF) (systolic HF [SHF]); the other half have HF with a normal EF (diastolic HF [DHF]). However, the underlying pathophysiological differences between DHF and SHF patients are incompletely defined. The purpose of this study was to use echocardiographic and implantable hemodynamic monitor data to examine the pathophysiology of chronic compensated and acute decompensated HF in SHF versus DHF patients. Methods and Results—Patients were divided into 2 subgroups: 204 had EF <50% (SHF) and 70 had EF Conclusions—Significant structural and functional differences were found between patients with SHF and those with DHF; however, elevated diastolic pressures play a pivotal role in the underlying pathophysiology of chronic compensated and acute decompensated HF in both SHF and DHF.
Accepted on July 10, 2008
Transition From Chronic Compensated to Acute Decompensated Heart Failure. Pathophysiological Insights Obtained From Continuous Monitoring of Intracardiac Pressures
Michael R. Zile MD*,
50% (DHF). DHF patients had EF of 58±8%, end-diastolic dimension of 50±10 mm, estimated resting pulmonary artery diastolic pressure (ePAD) of 16±9 mm Hg, and diastolic distensibility index (ratio of ePAD to end-diastolic volume) of 0.11±0.06 mm Hg/mL. In contrast, SHF patients had EF of 24±10%, end-diastolic dimension of 68±11 mm, ePAD of 18±7 mm Hg, and diastolic distensibility index of 0.06±0.04 mm Hg/mL (P<0.05 versus DHF for all variables except ePAD). In SHF and DHF patients who developed acute decompensated HF, these events were associated with a significant increase in ePAD, from 17±7 to 22±7 mm Hg (P<0.05) in DHF and from 21±9 to 24±8 mm Hg (P<0.05) in SHF. As a group, patients who did not have acute decompensated HF events had no significant changes in ePAD.
Related Article:
Circulation 2008 118: 1403-1404.
This article has been cited by other articles:
![]() |
F. Braunschweig, C. Linde, P. B. Adamson, A. Magalski, E. Erdmann, B. Kjellstrom, and T. Bennett Continuous central haemodynamic measurements during the six-minute walk test and daily life in patients with chronic heart failure Eur J Heart Fail, June 1, 2009; 11(6): 594 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Palardy, L. W. Stevenson, G. Tasissa, M. A. Hamilton, R. C. Bourge, T. G. DiSalvo, U. Elkayam, J. A. Hill, S. C. Reimold, and for the ESCAPE Investigators Reduction in Mitral Regurgitation During Therapy Guided by Measured Filling Pressures in the ESCAPE Trial Circ Heart Fail, May 1, 2009; 2(3): 181 - 188. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Lewis The role of the pulmonary vasculature in heart failure with preserved ejection fraction. J. Am. Coll. Cardiol., March 31, 2009; 53(13): 1127 - 1129. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |